Clinical study on the combined efficacy of gomutra haritaki tablet and nalpamaradi oil in Dermatophytosis

Open label single arm clinical study on the combined efficacy of gomutra haritaki vati and nalpamaradi taila in dadru (Dermatophytosis) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073705

Enrollment

Registered

2024-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants suffering with Dadru up to 1 year of duration. 2.Participants of either gender. 3.Participants aged between 18-60 years. 4.Participants willing to participate in the study and ready to sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Participants with Tinea mannus, Tinea pedis, Tinea unguium (Onychomycosis). 2.Participants with known case of uncontrolled Diabetes Mellitus (HbA1C greater than 8). 3.Participants with known case of Sexually Transmitted Diseases. 4.Patient taking any immune suppression drugs. 5.Pregnant women. 6.Lactating mother

Design outcomes

Primary

Measure	Time frame
1.Assessment will be based on the symptoms Kandu (Itching) , Raga (Erythema). 2.Pidaka (Eruption) , Mandala (Annular patches) , Centrifugal lesion , Well-demarcated borderTimepoint: 14 days	—

Secondary

Measure	Time frame
1.Pidaka. 2.Size of Mandala. 3.No. of Mandala. Timepoint: 14 DAYS	—

Countries

India

Contacts

Public ContactDR Totad Muttappa

Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital Hassan

drtotadmuttappa@sdmcahhassan.org9886924949

Outcome results